Ayyildiz, A., Koc, H., Turkekul, K., & Erdogan, S. (2023). Co-administration of apigenin with doxorubicin enhances anti-migration and antiproliferative effects via PI3K/PTEN/AKT pathway in prostate cancer cells. Experimental Oncology, 43(2), 125–134. https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-2.16096